StonvexLoading…
StonvexStonvexStonvexCore line items from KROS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $367.00K | $244.06M | $243.68M | $229.41M |
Operating Income | $-25.88M | $67.57M | $96.84M | $112.22M |
Net Income | $-23.71M | $87.01M | $110.47M | $-30.70M |
EPS (Diluted) | $-1.21 | $2.30 | $2.68 | $2.86 |
Total Assets | $312.29M | $338.02M | $742.78M | $757.16M |
Total Liabilities | $26.66M | $34.89M | $39.20M | $50.43M |
Cash & Equivalents | $281.50M | $287.42M | $693.47M | $690.22M |
Free Cash Flow OCF − CapEx | $-3.60M | $105.95M | $133.38M | $130.26M |
Shares Outstanding | 19.73M | 19.54M | 40.63M | 40.62M |